SRPT vs. ML

Last updated Jun 3, 2026

SRPT (Sarepta Therapeutics, Inc.) and ML (MoneyLion Inc.) are both stocks. SRPT operates in Biotechnology (Healthcare), while ML operates in Software - Application (Technology). At a 0.18 correlation, their price movements are largely independent.

Performance

SRPT vs. ML - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sarepta Therapeutics, Inc. (SRPT) and MoneyLion Inc. (ML). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

SRPT

• 1D: -7.72%
• 1M: -24.38%
• YTD: -24.49%
• 6M: -20.62%
• 1Y: -56.94%
• 3Y*: -49.36%
• 5Y*: -26.11%
• 10Y*: 0.43%

ML

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

SRPT vs. ML - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
SRPT Sarepta Therapeutics, Inc.	-24.49%	-82.30%	26.09%	-25.58%	43.90%	-47.18%	8.59%
ML MoneyLion Inc.	0.00%	-0.13%	37.20%	237.04%	-84.62%	-64.34%	15.31%

Correlation

The correlation between SRPT and ML is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.19
Correlation (All Time) Calculated using the full available price history since Aug 17, 2020	0.18

Fundamentals

Total Revenue (TTM) SRPT : $2.18B ML : $545.91M
Gross Profit (TTM) SRPT : $751.34M ML : $409.26M
EBITDA (TTM) SRPT : $107.91M ML : $56.96M

Return for Risk

SRPT vs. ML — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SRPT

SRPT Risk / Return Rank: 18
SRPT Sharpe Ratio Rank: 17
SRPT Sortino Ratio Rank: 22
SRPT Omega Ratio Rank: 21
SRPT Calmar Ratio Rank: 11
SRPT Martin Ratio Rank: 18

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SRPT vs. ML - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sarepta Therapeutics, Inc. (SRPT) and MoneyLion Inc. (ML). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SRPT	ML	Difference
Sharpe ratio Return per unit of total volatility	-0.55	—	—
Sortino ratio Return per unit of downside risk	-0.32	—	—
Omega ratio Gain probability vs. loss probability	0.95	—	—
Calmar ratio Return relative to maximum drawdown	-0.79	—	—
Martin ratio Return relative to average drawdown	-1.05	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	SRPT	ML	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.55	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.38	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.01	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.03	—	—

Drawdowns

Drawdown Indicators

	SRPT	ML	Difference
Max Drawdown Largest peak-to-trough decline	-98.17%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-72.26%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-92.72%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-92.72%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-93.33%	—	—
Current Drawdown Current decline from peak	-90.91%	—	—
Average Drawdown Average peak-to-trough decline	-68.14%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	53.85%	—	—

Volatility

Volatility by Period

	SRPT	ML	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.44%	—	—
Volatility (6M) Calculated over the trailing 6-month period	53.16%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	103.50%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	69.82%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	70.76%	—	—

Dividends

SRPT vs. ML - Dividend Comparison

Neither SRPT nor ML has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both SRPT and ML in my portfolio?

SRPT and ML have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.